Mumbai (Maharashtra) [India], September 26: aabo, a MedTech startup, released an upgraded version of its health and wellness wearable, the aaboRing. This avant-garde wearable made of titanium metal, which was launched in April this year, is thin, light weight, scratch proof robust and unbrea
According to a study, patients with obstructive sleep apnea (OSA) can lower their risk of dying from cardiovascular disease by sleeping with a continuous positive airway pressure (CPAP) machine.
According to a new study presented at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2023 Annual Scientific Meeting, bariatric surgery, also known as weight-loss or metabolic surgery, was associated with a 42% lower risk of major adverse cardiovascular events (MACE) such as
Obstructive sleep apnea is linked to an increased risk of long-term COVID. According to one study, persons with both sleep disturbance and COVID may benefit from clinical monitoring.
According to a recent study, those who suffer from sleep apnea and spend less time in deep sleep may be more likely to have brain biomarkers associated to an elevated risk of stroke, Alzheimer's disease, and cognitive decline.
Dena Zeraatkar and Tyler Pitre of McMaster University discovered that the medicine solriamfetol is the most effective therapy for excessive daytime sleepiness (EDS) in persons with obstructive sleep apnea (OSA).
According to a study published in the online issue of Neurology, the medical journal of the American Academy of Neurology, people who have sleep problems might be more likely to have a stroke.
Obstructive sleep apnea (OSA) is a disorder that could be harmful. People with OSA repeatedly cease breathing while they sleep because their throat muscles relax and restrict the airway to their lungs. The severely incapacitating symptoms of OSA for both patients and their partners include r
The drug, known as AF-130, was tested in an animal model at Waipapa Taumata Rau, the University of Auckland where researchers found it improved the heart's ability to pump, but, equally important, prevented sleep apnoea, which itself reduces lifespan (see Nature Communications).
According to a new study by Columbia University researchers, cholesterol-lowering medicines known as statins have the potential to minimise heart disease in persons with obstructive sleep apnea regardless of whether they use CPAP equipment at night.
A medication in development for obstructive sleep apnoea (OSA) showed promising results after being tested in humans for the first time by Flinders University researchers.